Quantapore Raises up to $35M for Development of Sequencing Platform | GenomeWeb

NEW YORK (GenomeWeb) – Nanopore-based sequencing firm Quantapore today announced it closed a Series B financing round raising up to $35 million.

The Menlo Park, Calif.-based firm did not disclose the name of the investors but said that the funds will go toward finalizing the development of its sequencing technology and commercializing its platform.

The final amount of the raise will depend on whether Quantapore meets certain milestones before all funds are released, Quantapore CEO Martin Huber said in an email.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.

Apr
13
Sponsored by
SeraCare

In this webinar, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay. 

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.